Britain and the United States are often described in the same breath: advanced economies that have moved beyond industry into services, finance, and knowledge work. On paper, the similarity looks strong. Services dominate employment and output in both countries, manufacturing has receded, and global cities anchor national growth. Yet the resemblance is superficial. The kinds of services each country produces, and the economic roles those services play, are profoundly different.
In the United States, the service sector has become a site of innovation, coordination, and control. Firms sell intelligence, analytics, and strategic advice at scale. Publishing houses and enterprise platforms shape not just markets but public discourse. Consultancies reorganize entire industries and software companies provide the backbone infrastructure for logistics, commerce, and finance itself. These are not support roles; they are high-productivity producer services that generate value far above the hourly work of a care worker or retail assistant. American finance energizes this ecosystem, serving not merely as a manager of wealth but as a creator of opportunity. As Jennifer J. Schulp and Norbert Michel’s Financing Opportunity explains, robust capital markets have been a foundational engine of American growth for more than two centuries, enabling the efficient allocation of risk, the scaling of firms, and the diffusion of capital to where it can spark innovation rather than merely sit idle.
Britain’s service sector paints a different picture. Outside a narrow elite layer of finance and law in London, most services are locally consumed, labor-intensive, and difficult to scale. Cafés, care homes, retailers, delivery firms, and administrative offices dominate employment. Even professional services frequently focus on compliance and regulation rather than strategic growth. These roles absorb labor but do not generate the compounding productivity that comes from deploying capital against ambitious, scalable ventures. The result is an economy that is busy but not dynamic, and employed workers who are far less empowered by the value their labor creates.
The consequences of this divergence show up starkly in wages. Simple projections from labor economists suggest that if UK productivity growth matched that of the United States, average UK workers could be around £4,000 a year better off on average, reflecting higher output per hour and more robust wage growth linked to capital deepening and innovation. This type of calculation is common in productivity debates comparing the UK and US, which show persistent gaps in output per hour worked. In America, workers in high-end producer services tend to earn wages commensurate with the value their work generates globally. In Britain, where services are often compensatory rather than commanding, wage growth is weaker and tied to local, low-productivity activities.
This difference ties directly to investment in innovation. Britain has a world-leading scientific base: its universities routinely produce highly-cited research and it generates more academic publications per head than almost any country. Among OECD countries, the UK has also been unusually generous in public support for business R&D. In 2021, it provided the largest government financial support to business R&D as a share of GDP, at 0.47 percent, more than double the OECD average of 0.22 percent. Over two-thirds of this support took the form of R&D tax relief, amounting to around 0.32 percent of GDP. Yet, despite this generosity, the commercial returns remain limited because of underinvestment by firms. British firms are much less likely to be among the world’s top R&D investors. In fact, the UK hosts only three of the top 100 industrial R&D spenders. The United States, by contrast, spends hundreds of billions annually on industrial R&D and hosts far more of the top global R&D investors, powering innovation that translates into new products and high‑growth companies.
Part of the problem is that British scientific excellence is concentrated in a relatively narrow set of specializations. Although the UK performs strongly in frontier fields such as artificial intelligence, quantum technologies, and synthetic biology, its presence in these areas is thin and involves relatively few firms. The ecosystem lacks depth. There are fewer companies capable of absorbing research at scale, fewer industrial platforms to deploy it, and fewer large domestic customers willing to take early technological risk. By contrast, American innovation ecosystems combine breadth with scale: many firms operating across adjacent sectors, competing, collaborating, and pulling new technologies rapidly into commercial use.
This gap matters. The UK’s challenge is not a lack of ideas; it is a commercialization problem. British science excels in discovery and publication, but the pathways to scale, to market entry, to venture funding, and to global adoption are weaker than in the US. Venture-backed companies frequently seek scale-up funding from abroad, especially from the United States, where deeper capital pools and a much larger domestic market are available. In practice, academic breakthroughs often migrate overseas to be developed and scaled rather than become British national champions. This weak link between research and commercial scaling produces a form of technological leakage: British science is commercialized elsewhere, and its productivity benefits are realized in economies with stronger industrial and service platforms.
Finance sits at the center of this dynamic. Where British finance tends to manage existing assets and allocate capital among established firms and global portfolios, American capital markets have historically been structured to flow into new ventures and bear risk. The structure of long-term savings is crucial here. In the United States, roughly 72 percent of venture capital funding ultimately comes from pension funds, compared to just around 10 per cent in the UK. In 1997, British pension funds allocated roughly half of their assets to UK equities; today, that figure has fallen to less than 5 percent. Limited risk tolerance, reinforced by regulation and liability-matching requirements, constrains the supply of patient capital. The result is weaker absorptive capacity: fewer firms able to take scientific advances, invest heavily, and turn them into scalable commercial systems.
As Schulp and her co-author argue, the breadth and depth of US markets—stock exchanges, venture capital networks, bond markets, and securitization mechanisms do not merely shift money around; they underpin how ideas become companies and how companies scale to global reach. This capacity to allocate risk and reward across time and place is a structural advantage that energizes innovation and sustains higher productivity growth.
Therefore the gap in research commercialization is sustained because of structural differences in British finance, which interacts with broader investment patterns. As such, Britain’s business investment both in capital goods and in R&D is lower relative to GDP than in the US and other leading economies. This has manifested in fewer mid-sized firms scaling into global challengers, and a smaller cohort of firms driving productivity gains. The 2024 Cambridge Industrial Innovation Policy report highlights that while the UK’s scientific output is excellent, value added per worker in medium- and high-value-added sectors is less than half that of the US, underscoring the persistent failure to translate knowledge into productive output.
Policy debates in the UK increasingly reflect this diagnosis. Business leaders have called for boosting R&D spending to “world-leading” levels and strengthening ties between universities and industry to foster commercialization, arguing that effective innovation investment could unlock long-term productivity and wage growth. But such reforms require not just more money, but deeper institutional change: stronger venture networks, more risk capital, and incentives that encourage firms to scale rather than shelter capital in low-risk assets such as property or passive financial holdings.
Ultimately, the difference between British and American services is not accidental; it is the product of historical choices about how finance is organized, how risk is treated, and what kind of social contract a society embraces. The United States tolerates volatility, inequality, and creative destruction in exchange for dynamic growth at the frontier. Britain, by contrast, prioritizes social stability and broad employment, cushioning its citizens from the harsher disruptions that often accompany innovation-driven growth. The result is a service economy that compensates for structural weaknesses rather than commands global systems of production and coordination.
The question, then, is not simply why Britain has so many low-level services while America produces publishing empires and intelligence firms; it is what Britain would have to change about its financial structures, innovation ecosystems, and social priorities to shift from a compensatory model to one that genuinely competes at the frontier of global services? The United States demonstrates what is possible when finance fuels innovation and firms scale; Britain’s challenge is to build the mechanisms that can translate its scientific strength into broad-based economic dynamism.
